The Journal of the Korean Rheumatism Association 2010; 17(4): 417-421
Published online December 30, 2010
© Korean College of Rheumatology
최우형ㆍ지은혜ㆍ이재호ㆍ김세원ㆍ민진수ㆍ박하욱ㆍ전병연ㆍ정연오ㆍ박경수ㆍ박성환ㆍ김호연
가톨릭대학교 의과대학 내과학교실
Correspondence to : Kyung-Su Park
Ankylosing spondylitis (AS) is occasionally accompanied by hematological malignancies such as myelodysplastic syndrome, acute myelogenous leukemia, or multiple myeloma. Chronic myelogenous leukemia (CML) is a myeloproliferative disorder associated with Philadelphia chromosome and is usually treated with imatinib, which inhibits tyrosine kinases. Although there have been reports of CML cases accompanied by several rheumatic diseases such as rheumatoid arthritis, Behcet's disease, systemic sclerosis, or undifferentiated spondylopathy, no studies have reported a case of CML with AS. We experienced a 50-year-old male patient who presented with buttock and low back pain and was diagnosed with both AS and CML. Magnetic resonance imaging showed sacroiliitis along with abnormal marrow infiltration, and a bone marrow biopsy confirmed the CML diagnosis. He was treated with imatinib, which was effective for the CML but not for the AS. This is the first case report of AS accompanied by CML.
Keywords Ankylosing spondylitis, Chronic myelogenous leukemia, Imatinib
The Journal of the Korean Rheumatism Association 2010; 17(4): 417-421
Published online December 30, 2010
Copyright © Korean College of Rheumatology.
최우형ㆍ지은혜ㆍ이재호ㆍ김세원ㆍ민진수ㆍ박하욱ㆍ전병연ㆍ정연오ㆍ박경수ㆍ박성환ㆍ김호연
가톨릭대학교 의과대학 내과학교실
Woo-Hyung Choi, Eun-Hye Ji, Jae-Ho Lee, Sei-Won Kim, Jin-Soo Min, Ha-Wook Park, Byoung-Yeon Jun, Yeon-Oh Jeong, Kyung-Su Park, Sung-Hwan Park, Ho-Youn Kim
Division of Rheumatology, Department of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea
Correspondence to:Kyung-Su Park
Ankylosing spondylitis (AS) is occasionally accompanied by hematological malignancies such as myelodysplastic syndrome, acute myelogenous leukemia, or multiple myeloma. Chronic myelogenous leukemia (CML) is a myeloproliferative disorder associated with Philadelphia chromosome and is usually treated with imatinib, which inhibits tyrosine kinases. Although there have been reports of CML cases accompanied by several rheumatic diseases such as rheumatoid arthritis, Behcet's disease, systemic sclerosis, or undifferentiated spondylopathy, no studies have reported a case of CML with AS. We experienced a 50-year-old male patient who presented with buttock and low back pain and was diagnosed with both AS and CML. Magnetic resonance imaging showed sacroiliitis along with abnormal marrow infiltration, and a bone marrow biopsy confirmed the CML diagnosis. He was treated with imatinib, which was effective for the CML but not for the AS. This is the first case report of AS accompanied by CML.
Keywords: Ankylosing spondylitis, Chronic myelogenous leukemia, Imatinib
Vitaly Omelchenko, M.D., Elena Letyagina, M.D., Maxim Korolev, M.D.
J Rheum Dis 2024; 31(4): 253-256Bon San Koo, M.D., Ph.D., Miso Jang, M.D., Ph.D., Ji Seon Oh, M.D., Ph.D., Keewon Shin, Ph.D., Seunghun Lee, M.D., Ph.D., Kyung Bin Joo, M.D., Ph.D., Namkug Kim, Ph.D., Tae-Hwan Kim, M.D., Ph.D.
J Rheum Dis 2024; 31(2): 97-107Inbeom Kwon, M.D., Nayeon Choi, M.S., Ji Hui Shin, M.S., Seunghun Lee, M.D., Ph.D., Bora Nam, M.D.,Ph.D., Tae-Hwan Kim, M.D., Ph.D.
J Rheum Dis 2024; 31(1): 41-48